Opko Health, Inc. Business Finance Contracts & Agreements
53 Contracts & Agreements
- Assignment Agreements (1 contract)
- Credit Agreements (13)
- Exchange Agreements (3)
- Indenture Agreements (3)
- Loan Agreements (3)
- Note Agreements (4)
- Purchase Agreements (5)
- Share Agreements (4)
- Stock Agreements (8)
- Subordination Agreement (1)
- Underwriting Agreements (2)
- Warrant Agreements (6)
- Form of Amended 5% Convertible Promissory Note dated February 10, 2023 (Filed With SEC on February 27, 2023)
- Waiver Under and Amendment No. 1 to Amended and Restated Credit Agreement, dated as of April 29, 2022, by and among BioReference Health LLC, GeneDx, LLC, the other subsidiary... (Filed With SEC on May 4, 2022)
- Asset Purchase Agreement, dated June 16, 2021, among EirGen Pharma Limited, Horizon Therapeutics Ireland DAC, and OPKO Health, Inc. (with respect to certain sections) (Filed With SEC on July 29, 2021)
- Form of Exchange Agreement, dated as of May 6, 2021, by and between OPKO Health Inc. and the applicable Noteholder (Filed With SEC on May 7, 2021)
- Amendment No. 12 to Credit Agreement, dated as of March 12, 2021, by and among BioReference Laboratories, Inc., certain of its subsidiaries, and JPMorgan Chase Bank, N.A (Filed With SEC on March 17, 2021)
- Credit Agreement, dated as of February 25, 2020, by and between OPKO Health, Inc. and Frost Gamma Investment Trust (Filed With SEC on March 2, 2020)
- Amendment No. 11 to Credit Agreement by and between BioReference Laboratories, Inc. and certain of its subsidiaries, and JPMorgan Chase, N.A. dated February 25, 2020 (Filed With SEC on March 2, 2020)
- Amendment No. 10 to Credit Agreement by and between BioReference Laboratories, Inc. and certain of its subsidiaries, and JPMorgan Chase, N.A. dated November 4, 2019 (Filed With SEC on March 2, 2020)
- Amendment No. 9 to Credit Agreement by and between BioReference Laboratories, Inc. and certain of its subsidiaries, and JPMorgan Chase, N.A. dated August 6, 2019 (Filed With SEC on November 5, 2019)
- Underwriting Agreement, dated February 4, 2019, by and between the Company and Jefferies LLC (Filed With SEC on October 29, 2019)
- Amendment No. 8 to Credit Agreement by and between BioReference Laboratories, Inc. and certain of its subsidiaries, and JPMorgan Chase, N.A. dated February 26, 2019 (Filed With SEC on May 8, 2019)
- Stock Purchase Agreement, dated as of November 8, 2018, between certain investors and OPKO Health, Inc (Filed With SEC on March 1, 2019)
- Credit Agreement, dated as of November 8, 2018, by and between the OPKO Health, Inc. and Frost Gamma Investments Trust (Filed With SEC on March 1, 2019)
- Share Lending Agreement, dated February 4, 2019, by and between the Company and Jefferies Capital Services, LLC (Filed With SEC on February 7, 2019)
- Form of 4.50% Convertible Senior Notes due 2025 (incorporated herein by reference to Exhibit A of the First Supplemental Indenture filed as Exhibit 4.3 to this Current Report on... (Filed With SEC on February 7, 2019)
- Base Indenture related to the 4.50% Convertible Senior Notes due 2025, dated as of February 7, 2019, by and between the Company and U.S. Bank National Association, as trustee (Filed With SEC on February 7, 2019)
- Underwriting Agreement, dated February 4, 2019, by and between the Company and Jefferies LLC (Filed With SEC on February 7, 2019)
- Amendment No. 7 to Credit Agreement by and between BioReference Laboratories, Inc. and certain of its subsidiaries, and JPMorgan Chase, N.A. dated February 28, 2018 (Filed With SEC on August 7, 2018)
- Form of 5% Convertible Promissory Note dated February 27, 2018 (Filed With SEC on March 1, 2018)
- Amendment No. 6 to Credit Agreement, dated as of December 22, 2017, among Bio-Reference Laboratories, Inc. and certain of its subsidiaries and JPMorgan Chase Bank, N.A (Filed With SEC on March 1, 2018)
- Amendment No. 5 to Credit Agreement, dated as of November 8, 2017, among Bio-Reference Laboratories, Inc. and certain of its subsidiaries and JPMorgan Chase Bank, N.A (Filed With SEC on March 1, 2018)
- Amendment No. 4 to Credit Agreement by and between Bio-Reference Laboratories, Inc. and certain of its subsidiaries and JPMorgan Chase Bank, N.A. dated August 7, 2017 (Filed With SEC on November 8, 2017)
- AMENDMENT NO. 3 TO CREDIT AGREEMENT (Filed With SEC on March 23, 2017)
- CREDIT AGREEMENT dated as of November 5, 2015, among BIO-REFERENCE LABORATORIES, INC., as the Company, The Subsidiaries from time to time party hereto as Subsidiary Borrowers, The... (Filed With SEC on February 29, 2016)
- DATED 5 May 2015 (1) SELLERS (2) OPKO IRELAND LIMITED FORM OF AGREEMENT FOR THE SALE AND PURCHASE OF SHARES IN EIRGEN PHARMA LIMITED McCann FitzGerald Solicitors Riverside One Sir... (Filed With SEC on August 5, 2015)
- DATED 5 May, 2015 (1) SELLERS (2) OPKO IRELAND LIMITED (3) OPKO HEALTH, INC. AGREEMENT FOR THE SALE AND PURCHASE OF SHARES IN EIRGEN PHARMA LIMITED McCann FitzGerald Solicitors... (Filed With SEC on August 5, 2015)
- SHARE PURCHASE AGREEMENT BY AND AMONG CYTOCHROMA INC., CYTOCHROMA HOLDINGS ULC, CYTOCHROMA CANADA INC. CYTOCHROMA DEVELOPMENT INC. PROVENTIV THERAPEUTICS, LLC CYTOCHROMA CAYMAN... (Filed With SEC on May 10, 2013)
- OPKO HEALTH, INC. 3.00% CONVERTIBLE SENIOR NOTES DUE 2033 INDENTURE DATED AS OF JANUARY 30, 2013 WELLS FARGOBANK, NATIONAL ASSOCIATION TRUSTEE Table of Contents (Filed With SEC on February 5, 2013)
- NOTE PURCHASE AGREEMENT (Filed With SEC on January 29, 2013)
- STOCK PURCHASE AGREEMENT (Filed With SEC on November 9, 2012)
- STOCK PURCHASE AGREEMENT (Filed With SEC on March 15, 2012)
- ASSET PURCHASE AGREEMENT (Filed With SEC on November 9, 2011)
- FORM OF RESTRICTED STOCK AGREEMENT FOR DIRECTORS (Filed With SEC on November 9, 2009)
- COMMON STOCK WARRANT (Filed With SEC on September 24, 2009)
- SECURITIES PURCHASE AGREEMENT dated as of September 18, 2009 by and among OPKO HEALTH, INC. AND THE PURCHASERS SET FORTH ON THE SIGNATURE PAGES HERETO (Filed With SEC on September 24, 2009)
- STOCK PURCHASE AGREEMENT (Filed With SEC on November 12, 2008)
- CONFIDENTIAL MATERIAL OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISKS DENOTE SUCH OMISSIONS. SECURITIES PURCHASE AGREEMENT (Filed With SEC on August 8, 2008)
- STOCK PURCHASE AGREEMENT (Filed With SEC on March 31, 2008)
- OPKO HEALTH, INC. - and - OTI HOLDINGS LIMITED - and - EACH HOLDER OF EXCHANGEABLE SHARES in the capital of OTI Holdings Limited EXCHANGE AND SUPPORT AGREEMENT DATED: November 28,... (Filed With SEC on March 31, 2008)
- SHARE PURCHASE AGREEMENT November 28, 2007 (Filed With SEC on March 31, 2008)
